{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:59:40Z","timestamp":1790841580658,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T00:00:00Z","timestamp":1368403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064145","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T17:04:37Z","timestamp":1368464677000},"page":"e64145","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":223,"title":["Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)"],"prefix":"10.1371","volume":"8","author":[{"given":"Maryssa","family":"Canuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Asselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustache","family":"Paramithiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annik","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil G.","family":"Seidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcna.2012.01.009","article-title":"LDL cholesterol: the lower the better","volume":"96","author":"SS Martin","year":"2012","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"MS Brown","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"FR Maxfield","year":"2005","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"M Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"M Marduel","year":"2012","journal-title":"Hum Mutat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"20799","DOI":"10.1074\/jbc.C700095200","article-title":"Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells","volume":"282","author":"MC McNutt","year":"2007","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"KN Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"S Benjannet","year":"2004","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"50630","DOI":"10.1074\/jbc.M410077200","article-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver","volume":"279","author":"SW Park","year":"2004","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1600-0854.2007.00562.x","article-title":"The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR","volume":"8","author":"N Nassoury","year":"2007","journal-title":"Traffic"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"S Rashid","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"A Zaid","year":"2008","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3699","article-title":"The biology and therapeutic targeting of the proprotein convertases","volume":"11","author":"NG Seidah","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"NG Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728220802600715","article-title":"PCSK9 as a therapeutic target of dyslipidemia","volume":"13","author":"NG Seidah","year":"2009","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"D Cunningham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"DW Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1073\/pnas.0712064105","article-title":"Molecular basis for LDL receptor recognition by PCSK9","volume":"105","author":"HJ Kwon","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1073\/pnas.0806312105","article-title":"Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor","volume":"105","author":"DW Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1074\/jbc.M110.199042","article-title":"A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor","volume":"286","author":"T Yamamoto","year":"2011","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced LDLR degradation: Evidence for an intracellular route","volume":"284","author":"S Poirier","year":"2009","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Luna Saavedra YG, Day R, Seidah NG (2012) The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 is needed for the extracellular low density lipoprotein receptor (LDLR) degradation pathway. J Biol Chem.","DOI":"10.1074\/jbc.M112.394023"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice","volume":"116","author":"TA Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein","volume":"292","author":"CK Garcia","year":"2001","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"44044","DOI":"10.1074\/jbc.M208539200","article-title":"ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2","volume":"277","author":"G He","year":"2002","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-8674(86)90533-7","article-title":"The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors","volume":"45","author":"CG Davis","year":"1986","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"KM Timms","year":"2004","journal-title":"Hum Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2010.05.003","article-title":"Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain","volume":"101","author":"TB Strom","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1593\/neo.121252","article-title":"Proprotein convertase subtilisin\/kexin type 9 deficiency reduces melanoma metastasis in liver","volume":"14","author":"X Sun","year":"2012","journal-title":"Neoplasia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.05-5491rev","article-title":"Proprotein convertases: lessons from knockouts","volume":"20","author":"N Scamuffa","year":"2006","journal-title":"FASEB J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"40965","DOI":"10.1074\/jbc.M110.154815","article-title":"Effects of the prosegment and pH on the activity of PCSK9: evidence for additional processing events","volume":"285","author":"S Benjannet","year":"2010","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"33745","DOI":"10.1074\/jbc.M112.399725","article-title":"Loss- and Gain-of-function PCSK9 Variants: Clevage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation","volume":"287","author":"S Benjannet","year":"2012","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase PCSK9 is inactivated by furin and\/or PC5\/6A: Functional consequences of natural mutations and post-translational modifications","volume":"281","author":"S Benjannet","year":"2006","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"S Poirier","year":"2008","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"G Dubuc","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.09.018","article-title":"Signaling through LRP1: Protection from atherosclerosis and beyond","volume":"81","author":"P Boucher","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1515\/CCLM.2011.154","article-title":"Low-density lipoprotein receptor-related protein 1: new functions for an old molecule","volume":"49","author":"M Franchini","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","article-title":"LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies","volume":"88","author":"AP Lillis","year":"2008","journal-title":"Physiol Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF01769358","article-title":"Drug sensitivity and metastatic ability in B16 melanoma cells","volume":"9","author":"A Jang","year":"1991","journal-title":"Clin Exp Metastasis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/07853890701214881","article-title":"The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions","volume":"39","author":"P May","year":"2007","journal-title":"Ann Med"},{"key":"ref41","first-page":"1533","article-title":"Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein","volume":"129","author":"DJ FitzGerald","year":"1995","journal-title":"J Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/ATVBAHA.110.220988","article-title":"Circulating Proprotein Convertase Subtilisin\/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue","volume":"31","author":"A Roubtsova","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.bi.63.070194.003125","article-title":"Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP)","volume":"63","author":"M Krieger","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s001090050356","article-title":"The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism","volume":"77","author":"TE Willnow","year":"1999","journal-title":"J Mol Med (Berl)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-012-0977-6","article-title":"PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling","volume":"69","author":"K Kysenius","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"31791","DOI":"10.1074\/jbc.M805971200","article-title":"Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels","volume":"283","author":"G Mayer","year":"2008","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e41865","DOI":"10.1371\/journal.pone.0041865","article-title":"Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation","volume":"7","author":"NG Seidah","year":"2012","journal-title":"PLoS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200601030","article-title":"ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages","volume":"174","author":"AW Jehle","year":"2006","journal-title":"J Cell Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)60771-5","article-title":"Effect of a monoclonal antibody to PCSK9, REGN727\/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial","volume":"380","author":"EA Stein","year":"2012","journal-title":"Lancet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.patbio.2008.07.015","article-title":"Multiple involvements of LRP-1 receptor in tumor progression","volume":"57","author":"B Langlois","year":"2009","journal-title":"Pathol Biol (Paris)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:39:37Z","timestamp":1540233577000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064145"}},"subtitle":[],"editor":[{"given":"Makoto","family":"Kanzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,13]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064145","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,13]]}}}